Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | FAAH | O00519 | 8/20 | 0.40 |
| ▸ | CES1 | P23141 | 3/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8986844 | 1.00 | TSHR (0.41) | TSHRFAAHCES1TRPV1LPAR1 | |
| SCHEMBL3397854 | 0.83 | TSHR (0.38) | TSHRFAAHCES1TRPV1LPAR1 | |
| SCHEMBL4493952 | 0.79 | TSHR (0.42) | TSHRFAAHTRPV1THRBMEN1 | |
| SCHEMBL4498202 | 0.79 | TSHR (0.42) | TSHRFAAHTRPV1THRBMEN1 | |
| SCHEMBL4501230 | 0.79 | TSHR (0.42) | TSHRFAAHTRPV1THRBMEN1 | |
| SCHEMBL4505586 | 0.79 | TSHR (0.42) | TSHRFAAHTRPV1THRBMEN1 | |
| SCHEMBL4506940 | 0.79 | TSHR (0.42) | TSHRFAAHTRPV1THRBMEN1 | |
| SCHEMBL2152771 | 0.79 | TSHR (0.42) | TSHRFAAHTRPV1THRBMEN1 | |
| SCHEMBL1118641 | 0.78 | FAAH (0.46) | FAAHCES1TRPV1MEN1TP53 | |
| SCHEMBL10866366 | 0.77 | FAAH (0.33) | TSHRFAAHCES1LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180352814-A1 | OXADIAZOLE COMPOUNDS AND USE FOR SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180352814-A1 | OXADIAZOLE COMPOUNDS AND USE FOR SAME | OXER1, NR4A3, NOX3 | TSHR 193/4885FAAH 4621/4885CES1 2354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.